Immune Activation in Primary Human Immunodeficiency Virus: Influence of Duration of Infection, Treatment, and Substance Use.
Gilada T, Schnittman SR, White E, Mercader J, Wang Y, Dasgupta S, Valdez R, Pinto-Santini D, Pasalar S, Sanchez J, Gonzales P, Lama JR, Bender Ignacio R, Duerr A.
Gilada T, et al. Among authors: white e.
Open Forum Infect Dis. 2022 Mar 24;9(6):ofac155. doi: 10.1093/ofid/ofac155. eCollection 2022 Jun.
Open Forum Infect Dis. 2022.
PMID: 35611350
Free PMC article.